Delphine Boche, Claire Paquet, Jacques Hugon, James Nicoll on Donanemab Confirms: Clearing Plaques Slows Decline—By a Bit
COMMENT Aβ immunotherapy has been considered as a treatment for Alzheimer’s disease for some years; however, the lack of clear cognitive efficiency associated with the presence of side effects in some patients has tempered enthusiasm. Nevertheless, the recent ...